최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.38 no.2, 2008년, pp.135 - 142
임현균 (중앙대학교 약학대학) , 이태호 (중앙대학교 약학대학) , 이재현 (중앙대학교 약학대학) , 염정록 (중앙대학교 약학대학) , 송진호 (중앙대학교 의과대학) , 한상범 (중앙대학교 약학대학)
The present study describes the evaluation of the bioequivalence of two atorvastatin tablets, Lipitor
J.W. Nawrocki, S.R. Weiss, M.H. Davidson, D.L. Sprecher, S.L. Schwortz, P.J. Lupien, P.H. Jones, H.E. Haber and D.M. Black, Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor, Arteriosclerosis, Thrombosis and Vascular Biololgy, 15, 678-682 (1995)
R.G. Bakker-Arkema, M.H. Davidson, R.J. Goldstein, J. Davignon, J.L. Isaacsohn, S.R. Weiss, L.M. Keilson, W.V. Brown, V.T. Miller, L.J. Shurzinske and D.M. Black, Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia, Journal of American Medical Association, 275, 128-133 (1996)
P. Jones, S. Kafonck, I. Laurora and D. Hunninghake, Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study), American Journal of Cardiology, 81, 582-587 (1998)
M. Guerin, P. Egger, C. Soudant, W. Le Goff, A. van Tol, R. Dupuis and M.J. Chapman, Dose-dependent action of atorvastatin in type B hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux, Atherosclerosis, 163, 287-296 (2002)
P.H. Chong, J.D. Seeger and C. Franklin, Clinically relevant differences between the statins: implications for therapeutic selection, Americal Journal of Medicine, 111, 390-400 (2001)
R. Koytchev, Y. Ozalp, A. Erenmemisoglu, M.J. van der Meer and R.S. Alpan, Bioequivalence study of atorvastatin tablets, Arzneimittelforschung, 54, 573-577 (2004)
V. Borek-Dohalsky, J. Huclova, B. Barrett, B. Nemec, I. Ulc and I. Jelinek, Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study, Analytical Bioanalytical Chmistry, 386, 275-285 (2006)
식품의약품안전청 고시 제 2007-65호, 생물학적동등성시험기준 (2007. 09. 20)
R.V.S. Nirogi, V.N. Kandikere, M. Shukla, K. Mudigonda, S. Maurya, R. Boosi and Y. Anjaneyulu, Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography-tandem mass spectrometry using rosuvastatin as internal standard, Biomedical Chromatography, 20, 924-936 (2006)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.